Takano, Kari-Ann Wong, Anita AL Brown, Rebecca Situ, Kathy Chua, Bernadette Anne Abu, Angel Elma Pham, Truc T Reyes, Glania Carel Ramachandran, Sangeetha Kamata, Masakazu
...
While studying transgene expression after systemic administration of lentiviral vectors, we found that splenic B cells are robustly transduced, regardless of the types of pseudotyped envelope proteins. However, the administration of two different pseudotypes resulted in transduction of two distinct B cell populations, suggesting that each pseudotyp...
Mudde, Anne CA Kuo, Caroline Y Kohn, Donald B Booth, Claire
During the past 20 years, gene editing has emerged as a novel form of gene therapy. Since the publication of the first potentially therapeutic gene editing platform for genetic disorders, increasingly sophisticated editing technologies have been developed. As with viral vector-mediated gene addition, inborn errors of immunity are excellent candidat...
Lance‐Byrne, Alissa Lindquist‐Kleissler, Brent Johnstone, Timothy C
Abstract: Structure elucidation plays a critical role across the landscape of medicinal chemistry, including medicinal inorganic chemistry. Herein, we discuss the importance of structure elucidation in drug development and then provide three vignettes that capture key instances of its relevance in the development of biologically active inorganic co...
Tullius, Michael V Bowen, Richard A Back, Peter S Masleša-Galić, Saša Nava, Susana Horwitz, Marcus A
Melioidosis, caused by the intracellular bacterial pathogen and Tier 1 select agent Burkholderia pseudomallei (Bp), is a highly fatal disease endemic in tropical areas. No licensed vaccine against melioidosis exists. In preclinical vaccine studies, demonstrating protection against respiratory infection in the highly sensitive BALB/c mouse has been ...
Liang, Christopher Paclibar, Cayz G Gonzaga, Noresa L Sison, Stephanie A Bath, Harman S Biju, Agnes P Mukherjee, Jogeshwar
Therapeutic antibodies for reducing Aβ plaque load in Alzheimer’s disease (AD) is currently making rapid progress. The diagnostic imaging of Aβ plaque load in AD has been underway and is now used in clinical studies. Here, we report our preliminary findings on imaging a therapeutic antibody, Lecanemab, in a postmortem AD brain anterior cingulate. [...
Samadi, Amirmasoud Moammeri, Ali Azimi, Shamim Bustillo-Perez, Bexi M Mohammadi, M Rezaa
The current paradigm of medicine is mostly designed to block or prevent pathological events. Once the disease-led tissue damage occurs, the limited endogenous regeneration may lead to depletion or loss of function for cells in the tissues. Cell therapy is rapidly evolving and influencing the field of medicine, where in some instances attempts to ad...
program, atomwise aims
High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that the predictive accuracy is sufficient to identify...
Drzewiecki, Carly M Fox, Andrew S
Anxiety disorders affect millions of people worldwide and present a challenge in neuroscience research because of their substantial heterogeneity in clinical presentation. While a great deal of progress has been made in understanding the neurobiology of fear and anxiety, these insights have not led to effective treatments. Understanding the relatio...
Oskotsky, Tomiko T Bhoja, Arohee Bunis, Daniel Le, Brian L Tang, Alice S Kosti, Idit Li, Christine Houshdaran, Sahar Sen, Sushmita Vallvé-Juanico, Júlia
...
Existing medical treatments for endometriosis-related pain are often ineffective, underscoring the need for new therapeutic strategies. In this study, we applied a computational drug repurposing pipeline to stratified and unstratified disease signatures based on endometrial gene expression data to identify potential therapeutics from existing drugs...
Lim, Raymond J Salehi-Rad, Ramin Tran, Linh M Oh, Michael S Dumitras, Camelia Crosson, William P Li, Rui Patel, Tejas S Man, Samantha Yean, Cara E
...
Immune checkpoint blockade (ICB) with PD-1/PD-L1 inhibition has revolutionized the treatment of non-small cell lung cancer (NSCLC). Durable responses, however, are observed only in a subpopulation of patients. Defective antigen presentation and an immunosuppressive tumor microenvironment (TME) can lead to deficient T cell recruitment and ICB resist...